These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2787716

  • 1. Interleukin 2 receptor expression by human blood lymphocytes after vaccination with pneumococcal polysaccharides.
    Tvede N, Heilmann C, Christensen LD.
    Clin Exp Immunol; 1989 Jun; 76(3):404-11. PubMed ID: 2787716
    [Abstract] [Full Text] [Related]

  • 2. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni.
    Yamashita T, Boros DL.
    J Immunol; 1990 Jul 15; 145(2):724-31. PubMed ID: 1973188
    [Abstract] [Full Text] [Related]

  • 3. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets.
    Shahabuddin S.
    J Clin Lab Immunol; 1991 Sep 15; 36(1):27-32. PubMed ID: 1668858
    [Abstract] [Full Text] [Related]

  • 4. In vitro study of expression of interleukin-2 receptors in T-lymphocytes from patients with IgA nephropathy.
    Lai KN, Leung JC, Lai FM.
    Clin Nephrol; 1988 Dec 15; 30(6):330-4. PubMed ID: 2977310
    [Abstract] [Full Text] [Related]

  • 5. Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor components.
    Kierszenbaum F, Cuna WR, Beltz LA, Sztein MB.
    J Immunol; 1989 Jul 01; 143(1):275-9. PubMed ID: 2659667
    [Abstract] [Full Text] [Related]

  • 6. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F, Moretti E, Sztein MB.
    Biol Res; 1993 Jul 01; 26(1-2):197-207. PubMed ID: 7670532
    [Abstract] [Full Text] [Related]

  • 7. IL-12 receptor. II. Distribution and regulation of receptor expression.
    Desai BB, Quinn PM, Wolitzky AG, Mongini PK, Chizzonite R, Gately MK.
    J Immunol; 1992 May 15; 148(10):3125-32. PubMed ID: 1578139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin 2 production, proliferative response, and receptor expression by cord blood mononuclear cells.
    Fairfax CA, Borzy MS.
    J Clin Lab Immunol; 1988 Oct 15; 27(2):63-7. PubMed ID: 3266760
    [Abstract] [Full Text] [Related]

  • 11. IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.
    Ben Aribia MH, Moiré N, Métivier D, Vaquero C, Lantz O, Olive D, Charpentier B, Senik A.
    J Immunol; 1989 Jan 15; 142(2):490-9. PubMed ID: 2783438
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Restricted expression of mitogen-induced high affinity IL-2 receptors in aging mice.
    Proust JJ, Kittur DS, Buchholz MA, Nordin AA.
    J Immunol; 1988 Dec 15; 141(12):4209-16. PubMed ID: 3264308
    [Abstract] [Full Text] [Related]

  • 14. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT, Grant AJ, Siegel JP.
    J Immunol; 1995 May 15; 154(10):5093-102. PubMed ID: 7730615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preferential expression of IL-2 receptor subunits on memory populations within CD4+ and CD8+ T cells.
    Taga K, Kasahara Y, Yachie A, Miyawaki T, Taniguchi N.
    Immunology; 1991 Jan 15; 72(1):15-9. PubMed ID: 1900055
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.
    Clin Cancer Res; 1997 Apr 15; 3(4):633-43. PubMed ID: 9815731
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.